跳至主要内容
临床试验/NCT04051346
NCT04051346已完成不适用

Dietary Oxalate and Innate Immunity in Kidney Stone Disease

University of Alabama at Birmingham2 个研究点 分布在 1 个国家目标入组 14 人开始时间: 2021年3月5日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
14
试验地点
2
主要终点
Change in Monocyte Subtypes

研究概览

简要总结

This study will test whether oxalate stimulates urinary crystals and impacts the immune system in healthy subjects using two controlled diets (low and high oxalate).

详细描述

Oxalate is a small molecule found in plants and plant-derived food. It has been shown that meals containing high amounts of oxalate can increase urinary oxalate excretion, which is a risk factor for calcium oxalate kidney stones (CaOx KS). Small increases in oxalate can stimulate urinary crystals to form which can elicit an immune response. This study consists of having healthy subjects consume both low and oxalate enriched diets to evaluate the effect of oxalate on urinary crystals and immune responses. Participants will receive a low or high oxalate diet for 4 days prior to having a wash out period for 6 days. Participants will then crossover to the opposite oxalate diet for four more days.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Healthy subjects (men and women) between the ages of 18 and 60 years of age
  • No calcium oxalate kidney stones or other medical conditions
  • Normal comprehensive metabolic panel (CMP)
  • Non tobacco users
  • Not pregnant
  • BMI between 20-30 kg/m2
  • Willing to abstain from vigorous exercise and vitamins/supplements during the study
  • Willing to consume only provided diets, accurately collect 24-hour urine samples, and have blood drawn

排除标准

  • Inability to sign and read the informed consent
  • Any medical, psychiatric, or social conditions that would prohibit participants from abiding by the study requirements
  • Physician refusal
  • Pregnant women
  • Active medical problems
  • History of kidney stones or any medical condition that could influence absorption or excretion of oxalate
  • Tobacco users
  • Taking medications or dietary supplements
  • BMI >30 or <20

结局指标

主要结局

Change in Monocyte Subtypes

时间窗: Days 1, 4, 11, and 14

Monocyte subtypes will be determined using flow cytometry (mean fluorescence intensity).

Change in Crystalluria

时间窗: Days 3-4 and 13-14

Crystalluria will be reported as particles/ml.

Change in Monocyte Cellular Energetics and Mitochondrial Function

时间窗: Days 1, 4, 11, and 14

Cellular energetics and mitochondrial function will be reported as oxygen consumption rate (pmol/min/10,000 cells).

Change in Urinary Oxalate

时间窗: Days 3-4 and 13-14

Twenty-four hour urinary oxalate will be reported as mg/day.

Change in Monocyte Transcriptomics

时间窗: Days 1, 4, 11, and 14

Monocyte cellular transcriptomics will be determined using RNA sequencing (mRNA).

Urinary Oxalate Excretion

时间窗: Days 4 and 14

Twenty-four hour urinary oxalate will be reported as mg/day.

Crystalluria

时间窗: Day 4 and 14

Crystalluria will be reported as particles/ml.

Number of Participants With Monocyte Cellular Energetics

时间窗: Days 4 and 14

Cellular energetic oxygen consumption traces will be examined.

次要结局

  • Number of Participants With Monocyte Transcriptomics(Days 4 and 14)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Tanecia Mitchell, PhD

Principal Investigator

University of Alabama at Birmingham

研究点 (2)

Loading locations...

相似试验